FI932831A - Ett foerfarande foer framstaellning av en syntetisk ledarsekvens - Google Patents

Ett foerfarande foer framstaellning av en syntetisk ledarsekvens Download PDF

Info

Publication number
FI932831A
FI932831A FI932831A FI932831A FI932831A FI 932831 A FI932831 A FI 932831A FI 932831 A FI932831 A FI 932831A FI 932831 A FI932831 A FI 932831A FI 932831 A FI932831 A FI 932831A
Authority
FI
Finland
Prior art keywords
syntetisk
ledarsekvens
etf
foerfarande foer
foer framstaellning
Prior art date
Application number
FI932831A
Other languages
English (en)
Other versions
FI932831A0 (fi
Inventor
Lars Christiansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI932831A0 publication Critical patent/FI932831A0/fi
Publication of FI932831A publication Critical patent/FI932831A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
FI932831A 1990-12-19 1993-06-18 Ett foerfarande foer framstaellning av en syntetisk ledarsekvens FI932831A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK300090A DK300090D0 (da) 1990-12-19 1990-12-19 Fremgangsmaade til fremstilling af leadersekvenser
PCT/DK1991/000396 WO1992011378A1 (en) 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences

Publications (2)

Publication Number Publication Date
FI932831A0 FI932831A0 (fi) 1993-06-18
FI932831A true FI932831A (fi) 1993-06-18

Family

ID=8118017

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932831A FI932831A (fi) 1990-12-19 1993-06-18 Ett foerfarande foer framstaellning av en syntetisk ledarsekvens

Country Status (17)

Country Link
EP (1) EP0563175A1 (fi)
JP (1) JPH06503957A (fi)
KR (1) KR930703450A (fi)
AU (1) AU660161B2 (fi)
CA (1) CA2098731A1 (fi)
CZ (1) CZ119293A3 (fi)
DK (1) DK300090D0 (fi)
FI (1) FI932831A (fi)
HU (1) HUT68751A (fi)
IE (1) IE914433A1 (fi)
IL (1) IL100408A0 (fi)
MX (1) MX9102684A (fi)
NZ (1) NZ241011A (fi)
PT (1) PT99848A (fi)
SK (1) SK62593A3 (fi)
WO (1) WO1992011378A1 (fi)
ZA (1) ZA919932B (fi)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI92601C (fi) * 1992-03-11 1994-12-12 Marja Makarow Menetelmä hyötyproteiinien erittämiseksi hiivoista
US5538863A (en) * 1993-07-01 1996-07-23 Immunex Corporation Expression system comprising mutant yeast strain and expression vector encoding synthetic signal peptide
US5639642A (en) * 1994-06-16 1997-06-17 Novo Nordisk A/S Synthetic leader peptide sequences
IL114160A (en) * 1994-06-17 2006-12-31 Novo Nordisk As Dna constructs encoding heterologous proteins and processes for the heterologous protein production in yeast
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
HRP940432B1 (en) * 1994-08-05 2003-10-31 Pliva Pharm & Chem Works Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin
NZ303162A (en) 1995-03-17 2000-01-28 Novo Nordisk As Enzyme preparations comprising an enzyme exhibiting endoglucanase activity appropriate for laundry compositions for textiles
BR9707807A (pt) 1996-03-01 1999-07-27 Novo Nordisk As Uso de uma composição farmacêutica composição farmacêutica processo de tratar doenças ou distúrbios associados com a regulação do apetite prejudicado e uso de um peptideo
DE69739319D1 (de) 1996-12-13 2009-04-30 Novartis Vaccines & Diagnostic Verfahren zur Expression von PDGF oder IGR Proteinen in Hefe
JP2003525570A (ja) 1998-01-23 2003-09-02 ノボ ノルディスク アクティーゼルスカブ 酵母において所望のポリペプチドを産生する方法
DE60044728D1 (de) 1999-12-29 2010-09-02 Novo Nordisk As VERFAHREN ZUR HERSTELLUNG VON INSULINVORLäUFERN UND ANALOGEN VON INSULINVORLÄUFERN MIT VERBESSERTER FERMENTATIONSAUSBEUTE IN HEFE
AT410217B (de) * 2000-06-15 2003-03-25 Cistem Biotechnologies Gmbh Vektor und ein verfahren zur expression und selektion randomisierter peptid-sequenzen
ES2432967T3 (es) 2001-03-22 2013-12-05 Novo Nordisk Health Care Ag Derivados del Factor VII de coagulación
ATE532858T1 (de) 2001-09-27 2011-11-15 Novo Nordisk Healthcare Ag Menschliche gerinnungsfaktor-vii-polypeptide
ES2381110T3 (es) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación
JP2007532096A (ja) 2003-11-14 2007-11-15 ノボ　ノルディスク　アクティーゼルスカブ アシル化されたインスリンの製造方法
ES2369895T3 (es) 2003-12-03 2011-12-07 Novo Nordisk A/S Insulina monocatenaria.
WO2005078116A1 (fr) * 2004-01-16 2005-08-25 Qiuyun Liu Methode permettant d'isoler de peptides antibacteriens et peptides isoles
ES2357550T3 (es) 2005-04-18 2011-04-27 Novo Nordisk A/S Variantes de la il-21.
CN102660614A (zh) 2005-08-16 2012-09-12 诺沃-诺迪斯克有限公司 制备成熟胰岛素多肽的方法
US20090055942A1 (en) 2005-09-14 2009-02-26 Novo Nordisk Healthcare A/G Human Coagulation Factor VII Polypeptides
ATE482977T1 (de) 2006-02-27 2010-10-15 Novo Nordisk As Insulinderivate
EP2069502B1 (en) 2006-09-27 2014-02-26 Novo Nordisk A/S Method for making maturated insulin polypeptides
WO2009021955A1 (en) 2007-08-13 2009-02-19 Novo Nordisk A/S Rapid acting insulin analogues
ES2526924T3 (es) 2007-08-15 2015-01-16 Novo Nordisk A/S Insulinas con una fracción acilo que comprende unidades repetitivas de aminoácidos que contienen alquilenglicol
EP2178912B1 (en) 2007-08-15 2015-07-08 Novo Nordisk A/S Insulin analogues with an acyl and aklylene glycol moiety
EP2406282A1 (en) 2009-03-11 2012-01-18 Novo Nordisk A/S Interleukin-21 variants having antagonistic binding to the il-21 receptor
AU2010272483B2 (en) 2009-07-17 2016-07-21 Omeros Corporation MASP isoforms as inhibitors of complement activation
EP2504355B1 (en) 2009-11-25 2015-07-22 Novo Nordisk A/S Method for making polypeptides
WO2011067283A1 (en) 2009-12-01 2011-06-09 Novo Nordisk A/S Novel peptidyl alpha-hydroxyglycine alpha-amidating lyases
ES2543634T3 (es) 2010-01-22 2015-08-20 Novo Nordisk A/S Proceso para preparación de FGF-21 con grado de O-glicosilación bajo
JP6148013B2 (ja) 2010-03-05 2017-06-14 リグショスピタレト 補体活性化のキメラ抑制分子
AU2011282988A1 (en) * 2010-07-28 2013-01-31 Smartcells, Inc. Recombinantly expressed insulin polypeptides and uses thereof
US11787844B2 (en) 2012-02-09 2023-10-17 Var2 Pharmaceuticals Aps Targeting of chondroitin sulfate glycans
JP2015532307A (ja) 2012-10-15 2015-11-09 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 凝固因子ｖｉｉポリペプチド
EP3004156A1 (en) 2013-06-07 2016-04-13 Novo Nordisk A/S Method for making mature insulin polypeptides
US20160376330A1 (en) * 2014-02-28 2016-12-29 Novo Nordisk A/S Mating factor alpha pro-peptide variants
CN112789504A (zh) 2018-07-13 2021-05-11 瓦克特诊断有限责任公司 使用重组疟疾蛋白var2csa分离胎儿来源的循环细胞

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK463887D0 (da) * 1987-09-07 1987-09-07 Novo Industri As Gaerleader
CA1340772C (en) * 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
JP3092811B2 (ja) * 1988-07-23 2000-09-25 デルタ バイオテクノロジー リミテッド ペプチドおよびｄｎａ配列
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid

Also Published As

Publication number Publication date
AU660161B2 (en) 1995-06-15
CZ119293A3 (en) 1994-02-16
ZA919932B (en) 1992-08-26
FI932831A0 (fi) 1993-06-18
WO1992011378A1 (en) 1992-07-09
CA2098731A1 (en) 1992-06-19
PT99848A (pt) 1993-06-30
IE914433A1 (en) 1992-07-01
HUT68751A (en) 1995-07-28
NZ241011A (en) 1993-04-28
SK62593A3 (en) 1993-10-06
DK300090D0 (da) 1990-12-19
AU9134891A (en) 1992-07-22
MX9102684A (es) 1992-06-01
EP0563175A1 (en) 1993-10-06
IL100408A0 (en) 1992-09-06
JPH06503957A (ja) 1994-05-12
HU9301801D0 (en) 1993-10-28
KR930703450A (ko) 1993-11-30

Similar Documents

Publication Publication Date Title
FI932831A (fi) Ett foerfarande foer framstaellning av en syntetisk ledarsekvens
FI924646A0 (fi) Oeverspaennings- och oeverstroemmsskydd foer ett linjeoeverdrag
FI913190A (fi) Sugluftfilter foer foerbraenningsmotorn av ett fordon.
FI910746A0 (fi) Foerfarande foer framstaellning av ett soetningssystem.
FI912833A0 (fi) Saendare omfattande ett elektroniskt arrangemang foer generering av en modulerad baervaogssignal.
FI913459A (fi) Vaeggorgan foer separering av vaetska fraon ett vaetskehaltigt partikelmaterial.
FI932368A0 (fi) Slitagebestaendiga komponenter foer ett kaernbraensleknippe
FI923070A (fi) Foerfarande foer avlaegsnande av kolvaeteprodukter fraon ytan av ett vattenmedium
FI913015A0 (fi) Stripningsfoerfarande foer avlaegsning av maskeringsfolie fraon ett kretskort.
FI921371A (fi) Anordning foer maetning av ett ledande skikt
FI920688A (fi) Anordning foer fastsaettning av ett sanitetsfoeremaol
FI914918A (fi) Foerfarande foer framstaellning av ett nytt terapeutiskt anvaendbart 5h-ben sodiazepinderivat.
FI902718A0 (fi) Foerfarande foer tillverkning av ett kompositstycke.
FI925876A0 (fi) Foerfarande foer framstaellning av ett virusinaktiverat protrombinkomplexkoncentrat
FI922715A (fi) Foerfarande foer kompensering av saendarnyttosignalens beroende av oeverfoeringsfunktionen foer ett combinerfilter
FI931853A (fi) Flerkanalig operation av ett radiodatasystem
FI906287A0 (fi) Maerkning av ett gjutstycke.
FI903923A (fi) Anordning foer aostadkommande av ett skidspaor.
FI925592A0 (fi) Ett nytt foerfarande foer framstaellning av 4-amino-5-hexensyra
FI931018A0 (fi) Anvaendning av ett 2-deoxistreptamin-typ antibioticum
FI88327B (fi) Foerfarande foer framstaellning av ett armeringsnaet
FI923785A (fi) Plasmaupphettning i ett slutet cirkulationssystem
FI932829A0 (fi) Foerfarande foer framstaellning av ett konserveringsmedel foer livsmedelsprodukter
FI913261A0 (fi) Foerfarande foer realisering av en koerbanundersoekning medelst ett reglerdon.
FI902668A0 (fi) Bestrykningsanordning foer bestrykning av ett roerligt underlag.

Legal Events

Date Code Title Description
FD Application lapsed